Xylem (NYSE: XYL) recently received a number of ratings updates from brokerages and research firms:
- 7/30/2026 – Xylem had its price target raised by UBS Group AG from $129.00 to $135.00. They now have a “neutral” rating on the stock.
- 7/29/2026 – Xylem had its price target raised by Mizuho from $124.00 to $130.00. They now have a “neutral” rating on the stock.
- 7/29/2026 – Xylem had its price target raised by Stifel Nicolaus from $157.00 to $160.00. They now have a “buy” rating on the stock.
- 7/29/2026 – Xylem had its “buy” rating reaffirmed by Citigroup Inc..
- 7/29/2026 – Xylem had its price target raised by Barclays PLC from $154.00 to $159.00. They now have an “overweight” rating on the stock.
- 7/29/2026 – Xylem had its price target raised by Royal Bank Of Canada from $159.00 to $164.00. They now have an “outperform” rating on the stock.
- 7/29/2026 – Xylem had its price target raised by Robert W. Baird from $163.00 to $165.00. They now have an “outperform” rating on the stock.
- 7/20/2026 – Xylem had its price target lowered by Stifel Nicolaus from $159.00 to $157.00. They now have a “buy” rating on the stock.
- 7/16/2026 – Xylem had its price target raised by Royal Bank Of Canada from $157.00 to $159.00. They now have an “outperform” rating on the stock.
- 6/25/2026 – Xylem was upgraded by Jefferies Financial Group Inc. from “hold” to “buy”. They now have a $140.00 price target on the stock, up from $130.00.
- 6/25/2026 – Xylem was upgraded by Jefferies Financial Group Inc. from “hold” to “buy”. They now have a $140.00 price target on the stock, up from $130.00.
- 6/25/2026 – Xylem was upgraded by CLSA to “hold”.
Xylem Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Thursday, June 25th. Shareholders of record on Thursday, May 28th were paid a $0.43 dividend. The ex-dividend date was Thursday, May 28th. This represents a $1.72 annualized dividend and a yield of 1.5%. Xylem’s payout ratio is presently 42.79%.
Insider Buying and Selling
In other news, CAO Geri-Michelle Mcshane sold 4,269 shares of the firm’s stock in a transaction that occurred on Thursday, May 7th. The shares were sold at an average price of $117.46, for a total transaction of $501,436.74. Following the completion of the transaction, the chief accounting officer directly owned 3,605 shares of the company’s stock, valued at $423,443.30. This trade represents a 54.22% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Jerome A. Peribere acquired 1,210 shares of the stock in a transaction dated Monday, May 4th. The stock was acquired at an average price of $116.61 per share, for a total transaction of $141,098.10. Following the completion of the acquisition, the director directly owned 27,209 shares of the company’s stock, valued at $3,172,841.49. The trade was a 4.65% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Corporate insiders own 0.32% of the company’s stock.
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- Chevron’s Strong Quarter Shows Why It Still Leads the Energy Sector
- Amazon’s Earnings Beat Shows Why AWS Is Back at the Center of the Bull Case
- Apple’s Record Quarter Could Not Outrun Its Guidance Problem
- McKesson’s Compounding Keeps Adding Up
Receive News & Ratings for Xylem Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem Inc and related companies with MarketBeat.com's FREE daily email newsletter.
